Cardiovascular Biotech Celladon Corporation Sets Terms for $75 Million IPO
Celladon, which is developing novel therapies for the treatment of heart disease, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Celladon would command a market value of $257 million.
Help employers find you! Check out all the jobs and post your resume.